Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550

Atrial fibrillation as an independent risk factor for stroke: the Framingham study

Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388

Angiotensin-neprilysin inhibition versus enalapril in heart failure

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 112

Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders

Farkowski, M. M., Scherr, D., Boriani, G., Kazakiewicz, D., Haim, M., Huculeci, R., Małaczyńska-Rajpold, K., Petersen, S. E., Timmis, A., TRAYKOV, V. B., et al. (2025) · EP Europace · doi:10.1093/europace/euaf124 · Cited by 36

Management of patients with atrial tachycardia: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), and the Association for European Paediatric and Congenital Cardiology (AEPC)

Meyer, C., Kahle, A., Dagres, N., Derval, N., Dewland, T. A., Drago, F., Eckardt, L., Frontera, A., Gerstenfeld, E. P., Hardy, C. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf324 · Cited by 25

The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice

Boriani, G., Mei, D. A., Vitolo, M., & Imberti, J. F. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04006-1 · Cited by 22

Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke

Mei, D. A., Romiti, G. F., Vitolo, M., Imberti, J. F., Corica, B., Mantovani, M., Bonini, N., Marín, F. R., Diemberger, I., Dan, G. A., et al. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf075 · Cited by 21

Impact of catheter ablation timing according to duration of atrial fibrillation history on arrhythmia recurrences and clinical outcomes: a meta-analysis

Karakasis, P., Tzeis, S. E., Pamporis, K., Schuermans, A., Theofilis, P., Milaras, N., Tsiachris, D., Efremidis, M., Antoniadis, A. P., & Fragakis, N. (2025) · EP Europace · doi:10.1093/europace/euaf110 · Cited by 26

Recent-onset atrial fibrillation: challenges and opportunities

Svennberg, E., Freedman, B., Andrade, J. G., Anselmino, M., Biton, Y., Boriani, G., Brandes, A., Buckley, C. M., Cameron, A. C., Clua‐Espuny, J. L., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf478 · Cited by 24

Lifestyle and risk factor modification in atrial fibrillation: a European Heart Rhythm Association survey

Mills, M. T., Futyma, P., Calvert, P. A. R., Penela, D., Roten, L., Perrotta, L., Migliore, F., Lip, G. Y. H., Gupta, D., & Chun, K. R. J. (2025) · EP Europace · doi:10.1093/europace/euaf075 · Cited by 16

Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry

Boriani, G., Mei, D. A., Bonini, N., Vitolo, M., Imberti, J. F., Romiti, G. F., Corica, B., Diemberger, I., Dan, G., Potpara, T., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.04.038 · Cited by 14

Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation

Ciconte, G., Salerno, R., Fuga, A., Vuturo, A., Boccellino, A., Negro, G., Rondine, R., Ballarotto, M., Ciaccio, C., Izzo, A., et al. (2026) · EP Europace · doi:10.1093/europace/euag018 · Cited by 12

Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation: an analysis from UK Biobank

Ahn, H., Rhee, T., Choi, E., Lee, K., Choi, J., Kim, J.-H., Han, S., Kwon, S., Lee, S., Oh, S., et al. (2025) · EP Europace · doi:10.1093/europace/euaf104 · Cited by 11

Feasibility, procedural efficiency, and early imaging outcomes of concomitant pulsed field ablation and left atrial appendage closure: a prospective single-centre study

Doty, B., Mraiyan, M., Nair, G., Khan, M. R., Gabrah, K., & Nair, D. G. (2026) · EP Europace · doi:10.1093/europace/euag017 · Cited by 10

Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial

Boriani, G., McIntyre, W. F., Ramasundarahettige, C. F., Proietti, M., Glotzer, T. V., Diemberger, I., Nielsen, J. C., Essebag, V., Granger, C. B., Sandhu, R. K., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.07.002 · Cited by 10

Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes

Brügger, J., Isenegger, C., Jordan, F., Subin, B., Stump, R., Knecht, S., Spreen, D., Schaerli, N., Krisai, P., Schaer, B. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf265 · Cited by 10

Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry

Mei, D. A., Imberti, J. F., Vitolo, M., Romiti, G. F., Corica, B., Mantovani, M., Bonini, N., Cherubini, B., Marín, F. R., Diemberger, I., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106512 · Cited by 9

Association between comorbidity burden and outcomes of catheter ablation vs. medical therapy for atrial fibrillation: insights from the CABANA trial

Chen, Y., Soler‐Espejo, E., Zhao, M., Li, W., Liu, H., Gue, Y. X., McDowell, G., Packer, D. L., & Lip, G. Y. H. (2025) · EP Europace · doi:10.1093/europace/euaf292 · Cited by 10

Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants

Chan, Y., Kao, Y., Chen, S., & Chao, T.-F. (2025) · EP Europace · doi:10.1093/europace/euaf251 · Cited by 8

European Heart Rhythm Association survey on the perceived severity of complications in atrial fibrillation ablation: development of a standardized scoring model

Bordignon, S., Mills, M. T., Futyma, P., Sultan, A., Metzner, A., Migliore, F., Perrotta, L., Anić, A., Merino, J. L., Pürerfellner, H., et al. (2025) · EP Europace · doi:10.1093/europace/euaf254 · Cited by 9

Acute outcomes and learning curve from the initial patients treated with the PulseSelect system: a real-world multicenter experience of pulsed field ablation

Molon, G., Nardi, S., Mitacchione, G., Russo, A. D., Ricciardi, D., Mantovan, R., Bontempi, L., Costa, A., Argenziano, L., Casali, E., et al. (2025) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-025-02036-5 · Cited by 7

Acute durability of cavotricuspid isthmus block after pulsed electric field ablation: randomized comparison of two pentaspline catheter configurations (SECTION trial)

Stojadinovic, P., Wichterle, D., Bulava, A., Plášek, J., Havránek, Š., Peichl, P., Ventrella, N., Marek, J. J., Borisincova, E., Stiavnicky, P., et al. (2025) · EP Europace · doi:10.1093/europace/euaf234 · Cited by 6

Optimized workflow for pentaspline PFA and its impact on PVI durability: evidence from systematic remapping

Muñoz, D. R., Gálvez, L. C., Al-Mahdi, E. A. R., Alacid, I. L., Jiménez, J. R., Castillo, A. M. D., Bernabé, L. B., Caamaño, M. N., Burgueño, L. G., Arribas, F., et al. (2026) · EP Europace · doi:10.1093/europace/euag118 · Cited by 6

Superior vena cava isolation with 3D mapping using a novel balloon-in-basket pulsed field ablation catheter

Papakonstantinou, P. Ε., & O’Brien, J. (2025) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-025-02158-w · Cited by 5

Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials

Karakasis, P., Tzeis, S. E., Samaras, A., Vlachos, K. G., Pamporis, K., Theofilis, P., Tzikas, A., Antoniadis, A. P., Jaı̈s, P., & Fragakis, N. (2026) · EP Europace · doi:10.1093/europace/euag159 · Cited by 5

Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study

Anjum, M., Ariansen, I., Myrstad, M., Kjerpeseth, L. J., Hjellvik, V., Skovlund, E., Christophersen, I. E., Tveit, A., & Berge, T. (2025) · EP Europace · doi:10.1093/europace/euaf145 · Cited by 6

Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study

Kim, H. E., Yang, P., Park, H., Kim, D., Bae, H., Lee, C., Son, J., Kim, U., & Joung, B. (2025) · EP Europace · doi:10.1093/europace/euaf286 · Cited by 5

Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

Zhang, T., He, X., Fu, G., Liu, H., Yi, F., Liu, J., Wang, P., Chen, Z., Zhao, X., Chu, H., et al. (2026) · EP Europace · doi:10.1093/europace/euag022 · Cited by 4

Stroke in Dilated Cardiomyopathy: An Autopsy-Based Study of Mechanisms, Topography, and Clinical Implications

Țica, O., Sabau, M., Venter, A. C., Beiușanu, C., Berechet, M. C., Huniadi, A. C., Şandor, M. I., & Ţică, O. (2025) · Diagnostics · doi:10.3390/diagnostics15182287 · Cited by 4

Patients’ experiences of atrial fibrillation and comorbidity management in clinical practice: a pan-European qualitative descriptive interview study

Lee, G., Baker, E. J., Heidbuchel, H., Önder, R., Mulder, B. A., Dąbrowski, R., Tzeis, S. E., Karanikas, S., Jauregui-Abularach, M. E., Merino, D. O., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094839 · Cited by 3

Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation

Neužil, P., de Loma-Osorio, A. F., Martínez-Brotons, Á. M., Saavedra, L. B., Mei, D. A., Moučka, P., Uffenorde, S., Ruiz, J. V., & Boriani, G. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2575460 · Cited by 3

Impact of pulsed field vs. radiofrequency on atrial fibrillation ablation workflow and organization: a single high-volume centre experience

Ciliberti, D., Monaco, A. D., Quadrini, F., Troisi, F., Vitulano, N., Caporusso, N., Sgarra, L., Perniciaro, V., Caruso, R., Anzelmo, V., et al. (2025) · EP Europace · doi:10.1093/europace/euaf267 · Cited by 3

Machine learning prediction of outcome following pulsed-field atrial fibrillation ablation: patient selection and risk factors

Anselmino, M., Bianchi, S., Lucia, R. D., Tondo, C., Iacopino, S., Solimene, F., Rossillo, A., Bertini, M., Themistoclakis, S., Meynet, I., et al. (2026) · EP Europace · doi:10.1093/europace/euag053 · Cited by 3

Transseptal puncture in cardiovascular interventions: a clinical consensus statement of the European Heart Rhythm Association, the Heart Failure Association, the European Association of Percutaneous Cardiovascular Interventions, the European Association of Cardiovascular Imaging of the ESC, and the Association for European Paediatric and Congenital Cardiology

Deisenhofer, I., Abdelhamid, M., Adamo, M., Marsan, N. A., Amabile, N., Bisceglia, C., Boersma, L. V. A., Álvarez, B. C., Cornara, S., Delgado, V., et al. (2026) · EP Europace · doi:10.1093/europace/euag021 · Cited by 3

Catheter Ablation as the First-Line Therapy for Atrial Fibrillation: Update on Evidence and Clinical Implications

Fatunde, O. A., & Shen, W.-K. (2025) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2025.0001 · Cited by 3

Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 2022

Vinter, N., Johnsen, S. P., Benjamin, E. J., Lip, G. Y. H., & Frost, L. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf026 · Cited by 3

Unusual Evolution of Carotid Atherosclerosis in a Patient with Transient Ischemic Attack

Cinezan, C., Rus, C. B., Ilias, I. T., Comanescu, A. D., & Cinezan, A. (2025) · Life · doi:10.3390/life15060831 · Cited by 3

Stroke Risk Stratification in Incident Atrial Fibrillation: A Sex-Specific Evaluation of CHA2DS2-VA and CHA2DS2-VASc

Clua‐Espuny, J. L., Panisello-Tafalla, A., Lucas-Noll, J., Múria-Subirats, E., Forcadell-Arenas, T., Carrera-Ortiz, J. M., Moltó-Balado, P., Clua-Queralt, J., Anguera, I. F., & Reverté‐Villarroya, S. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12070259 · Cited by 3

Female sex as risk factor for undertreatment: need for a paradigm shift in the care of atrial fibrillation and ischaemic disease

Corica, B., Mei, D. A., & Boriani, G. (2025) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2025.2453790 · Cited by 3

Does the type of oral anticoagulant matter for stroke prevention or bleeding in patients with atrial fibrillation after cardiac surgery? A systematic review and meta-analysis

Terpstra, M. M., de Vries, T. A. C., Oortwijn, E., van Wijngaarden, R. A. F. D. L., & de Groot, J. R. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf062 · Cited by 3

Leitfaden zur sicheren und effektiven Vorhofflimmerablation mit Pulsed Field Ablation am Beispiel des pentaspline PFA‑System

Reinsch, N., Johnson, V., Rolf, S., Busch, S., Ebert, M., Maurer, T., Tilz, R. R., Althoff, T. F., Chun, K. R. J., Duncker, D., et al. (2025) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-025-01071-z · Cited by 2

N-palmitoyl glycine mediates depression-associated atrial fibrillation via Man1a2-dependent autophagy and NRAP dysregulation

Chen, J., Sheng, S., Zhang, J., Li, Y., Jiang, T., Jiang, X., Li, J., Lv, L. L., Wang, Z., Wei, Y., et al. (2025) · EP Europace · doi:10.1093/europace/euaf127 · Cited by 2

Microbubble and thermal profile of an eight-spline pulsed field ablation system in a pre-clinical model

Niemiera, B., Ranjan, R., Piccini, J. P., Nguyen, J., Mittal, L., Pipenhagen, C. A., Overmann, J. A., Spangler, T. B., & Sundaram, S. (2025) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-025-02145-1 · Cited by 2

Risk of cancer following presentation with new-onset atrial fibrillation using data from UK national databases

Yoshimura, H., Zakkak, N., Lyratzopoulos, G., Lip, G. Y. H., Schmidt, A. F., & Providencia, R. A. (2025) · EP Europace · doi:10.1093/europace/euaf319 · Cited by 2

Prothrombin complex concentrate for reversal of factor Xa inhibitor-associated acute major gastrointestinal bleeding

Shamiea, M., Kashua, A., Natour, A. E. H., Butnik, Y., Ifrach, N., Avnery, O. H., Itchaki, G., Osnis, A., Rabina, E., Kabaha, N., et al. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.01.010 · Cited by 2

Contemporary management of atrial fibrillation in patients with cancer—the 2025 European Heart Rhythm Association survey

Farkowski, M. M., Szmit, S., Boriani, G., Castrejón, S. C., Fradley, M. G., Guha, A., Merino, J. L., Mugnai, G., Lee, G., Lyon, A. R., et al. (2026) · EP Europace · doi:10.1093/europace/euaf325 · Cited by 2

Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey

Fengsrud, E., Blomström‐Lundqvist, C., Camm, A. J., Goette, A., Kowey, P. R., Merino, J. L., Piccini, J. P., Saksena, S. V., Reiffel, J. A., & Boriani, G. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101709 · Cited by 2

The role of pharmacists in the management of patients with atrial fibrillation: A systematic review and meta-analysis

Tonin, F. S., Tsuyuki, R. T., Fernández-Llimós, F., García‐Cárdenas, V., Laufs, U., & Schulz, M. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251365148 · Cited by 2

The evolving epidemiological landscape of atrial fibrillation: trends, challenges, and opportunities for improved patient care

Zuin, M., Bertini, M., & Boriani, G. (2025) · EP Europace · doi:10.1093/europace/euaf026 · Cited by 2

Effect of Wall Motion Sampling on CFD ‐Derived Left Atrial Flow Metrics

Stöcker, Y., Guerrero‐Hurtado, M., Durán, E., Gonzalo, A., Ristić, Z., Telle, Å., Kassar, A., Haykal, R., AKOUM, N. W., Boyle, P. M., et al. (2026) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1101/2025.10.24.684343 · Cited by 4

Diagnostic heterogeneity and healthcare disparities: an underestimated source of bias in atrial fibrillation global burden estimates

Bisson, A., Lenormand, T., & Fauchier, L. (2025) · EP Europace · doi:10.1093/europace/euaf114 · Cited by 1

Impact of cryoballoon size adjustability on procedural and clinical outcomes

Kikkoji, N., Miyazaki, S., Nitta, J., Sasaki, T., Yamauchi, Y., Yamashita, S., Sagawa, Y., Shirai, Y., Inaba, O., Suzuki, A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf211 · Cited by 1

Actividad física en pacientes con fibrilación auricular y eventos adversos: resultados de un estudio de cohortes prospectivo multicéntrico europeo

Vitolo, M., Proietti, M., Mantovani, M., Imberti, J. F., Mei, D. A., Bonini, N., Romiti, G. F., Corica, B., Diemberger, I., Fauchier, L., et al. (2025) · Revista Española de Cardiología · doi:10.1016/j.recesp.2025.07.010 · Cited by 1

Ablation of atrial fibrillation sources identified through sequential high-density mapping: in silico comparison against anatomy-based approaches

Marques, V. G., Gharaviri, A., Özgül, O. F., Pezzuto, S., Auricchio, A., Vernooy, K., Linz, D., Hermans, B. J. M., Bonizzi, P., Zeemering, S., et al. (2025) · EP Europace · doi:10.1093/europace/euaf304 · Cited by 1

Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study

Wang, Z., Yang, F., Wang, Q., Xia, X., & Lv, Q. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04004-y · Cited by 1

Present state and future of screening for atrial fibrillation: a state-of-the-art review

Svennberg, E., & Khan, M. (2026) · Heart · doi:10.1136/heartjnl-2025-326121 · Cited by 2

Association of atrial high-rate episodes daily burden with the risk of cardiovascular death, heart failure hospitalization, and stroke

Botto, G. L., Pisanò, E., Rapacciuolo, A., Lazzari, L., Bontempi, L., Pelargonio, G., Arena, G., Caccavo, V., Wang, C.-C., Merkley, B., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.048 · Cited by 1

Improving healthcare delivery for patients with atrial fibrillation. Opinion on the problem

Lebedev, D. S., & Ermolov, S. A. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6775 · Cited by 1

Global burden of heart failure attributable to atrial fibrillation and flutter, insights from GBD 2021

Xiong, J., Guan, S., Cheng, C., Zhang, Y., Chen, S. R. W., Wang, J., Yang, X., Wang, H., Pan, F., & Yu, R. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag094 · Cited by 1

Comparison of the effectiveness and safety of dronedarone and amiodarone for preventing recurrence after catheter ablation of atrial fibrillation: an open-label randomized controlled trial

Zhang, X., Jiang, R., Chen, Y., Lou, L., Liu, S., Sok, T., Han, J., Zhou, D., Zhang, B., Li, Z., et al. (2026) · EP Europace · doi:10.1093/europace/euag095 · Cited by 1

Application of Artificial Intelligence in the Early Detection and Management of Atrial Fibrillation: State-of-the-art Review

Mei, D. A., Cherubini, B., Imberti, J. F., Orlandi, M., Vitolo, M., & Boriani, G. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.74 · Cited by 1

Impact of pre-operative factors on post-operative atrial fibrillation outcomes after cardiac surgery: systematic review with meta-analysis, trial sequential analysis, and meta-regression

Khalil, I., Hrebat, M., Abuawwad, T., Zetawi, M., Yassin, B. M., Amayre, S. I., Amarin, H., Gouda, A. G., Khazbak, M. A., Khatib, S., et al. (2026) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2026.2664905 · Cited by 1

Asymptomatic atrial fibrillation in patients treated with BTK inhibitors in hematologic malignancies: a systematic review and metanalysis

Boriani, G., Imberti, J. F., Valenti, A. C., Vitolo, M., López‐Fernández, T., & Mei, D. A. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106994 · Cited by 1

Fluoroless high-density pulsed field vs radiofrequency ablation for atrial fibrillation guided by left atrial intracardiac echocardiography: The HALO protocol

Saad, G., Slater, C., Fernandes, J. A., dos Santos, G. V., Oliveira, L. A., & Saad, E. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.06.011 · Cited by 1

Autonomic effects and ablation success after pulsed field and cryoballoon ablation: a SINGLE SHOT CHAMPION substudy

Roten, L., Kueffer, T., Badertscher, P., Jüni, P., Knecht, S., Thalmann, G., Kozhuharov, N., Krisai, P., Iqbal, S. U. R., Jufer, C., et al. (2026) · EP Europace · doi:10.1093/europace/euag152 · Cited by 1

From the arrhythmia to the substrate: the role of atrial cardiomyopathy in atrial fibrillation management

Gerra, L., Dall’Ospedale, V., Boriani, G., & Aschieri, D. (2026) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2026.2695396 · Cited by 1

Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

Peretto, G., Basso, C., Berruezo, A., Bollano, E., Caforio, A. L. P., Casella, M., de Chillou, C., Ebert, M., Gati, S., Imazio, M., et al. (2026) · EP Europace · doi:10.1093/europace/euag153 · Cited by 1

Patient preferences for stroke prevention treatments in atrial fibrillation in Asia: A discrete choice experiment

Wang, R., Lu, H., Fernandez, G. S., Krucien, N., Huang, D., Higashiyama, H., Du, J., Ye, X., Tervonen, T., & Quaife, M. (2025) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2025.103084 · Cited by 1

Educating healthcare professionals to improve AF-CARE: lessons from the ESC/EHRA STEEER-AF trial educational programme

van Deutekom, C., Bunting, K. V., Potter, T. J. R. D., Gelder, I. C. V., Kotecha, D., leads, S.-A. E., Robinson, T. G., Potpara, T., Marijon, É., Defaye, P., et al. (2025) · EP Europace · doi:10.1093/europace/euaf142 · Cited by 1

Update der ESC-Vorhofflimmerleitlinien 2024

Schnabel, R. B., Gunawardene, M., Perings, C. A., Steven, D., Busch, H.-J., Deisenhofer, I., Häusler, K. G., Sommer, P., Birkemeyer, R., Eckardt, L., et al. (2025) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-025-01096-4 · Cited by 1

Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey?

Mei, D. A., Tritto, F. P., Imberti, J. F., Vitolo, M., & Boriani, G. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106455 · Cited by 1

Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future?

Vitolo, M., Mei, D. A., & Boriani, G. (2025) · EP Europace · doi:10.1093/europace/euaf063 · Cited by 1

From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients

Mei, D. A., Imberti, J. F., & Boriani, G. (2025) · EP Europace · doi:10.1093/europace/euaf215 · Cited by 1

EP Europace: the journey continues, looking ahead to 2025 and beyond

Boriani, G. (2024) · EP Europace · doi:10.1093/europace/euaf006

Atrial fibrillation screening: The importance of the patient perspective

Imberti, J. F., Mei, D. A., & Boriani, G. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.02.028

Optimization of oral anticoagulation in patients with atrial fibrillation: The challenge remains open

Boriani, G., Serafini, K., & Imberti, J. F. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70023

Genomic medicine for heart failure prediction in patients with atrial fibrillation

Wijdeveld, L. F. J. M., & Jurgens, S. J. (2025) · EP Europace · doi:10.1093/europace/euaf113

Atrial fibrillation—lost lifetimes and the urgent need for outcome-driven management

Hillmann, H. A. K., Müller‐Leisse, J., & Duncker, D. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf042

Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study

Jalli, E., Jaakkola, J., Langén, V. L., Airaksinen, J. K. E., Halminen, O., Jukka Putaala, A., Mustonen, P. E., Haukka, J. K., Hartikainen, J. E. K., Linna, M., et al. (2025) · EP Europace · doi:10.1093/europace/euaf155

Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort

Vitolo, M., Proietti, M., Mantovani, M., Imberti, J. F., Mei, D. A., Bonini, N., Romiti, G. F., Corica, B., Diemberger, I., Fauchier, L., et al. (2025) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2025.07.005

Impact of comorbidity patterns on mortality and length of stay in hospitalized patients with atrial fibrillation: a cohort study

Ng, H. S., Woodman, R. J., & Mangoni, A. A. (2025) · Postgraduate Medical Journal · doi:10.1093/postmj/qgaf133

When age meets genetics: refining heart failure risk prediction in young atrial fibrillation

Deng, B., & Liu, W. (2025) · EP Europace · doi:10.1093/europace/euaf201

Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: a sub-analysis of the SUPPRESS-AF trial

Matsuda, Y., Masuda, M., Mano, T., Tsujimura, T., Uematsu, H., Ooka, H., Kudo, S., Ochi, M., Okamoto, S., Ishihara, T., et al. (2025) · EP Europace · doi:10.1093/europace/euaf205

Apixaban in subclinical atrial fibrillation: stroke-driven value amid economic uncertainty

Yeh, C.-H., & Chen, S. (2025) · EP Europace · doi:10.1093/europace/euaf262

Repeat ablation for persistent atrial fibrillation: what lies beyond lines and veins?

Boersma, L. V. A., & Yap, S. (2025) · EP Europace · doi:10.1093/europace/euaf269

Possibilities of prevention and treatment of deep vein thrombosis in the lower limbs after arrhythmia-related catheter interventions

Abishev, A. M., Борисович, Ш. Н., Tripoten, M. I., Погорелова, О. А., Yarovoy, S. Y., Mironov, N. Y., Новиков, П. С., & Balakhonova, T. V. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-4-82-87

The role of sarcopenia in determining the risk of adverse events in atrial fibrillation: advancing the need for a geriatric approach

Proietti, M., Ronca, A., & Boriani, G. (2025) · EP Europace · doi:10.1093/europace/euaf310

Alcohol use disorder and use of rhythm control therapies in patients with atrial fibrillation: A nationwide cohort study

Vanhanen, M., Jaakkola, J., Airaksinen, J. K. E., Halminen, O., Jukka Putaala, A., Mustonen, P. E., Haukka, J. K., Hartikainen, J. E. K., Luojus, A., Niemi, M., et al. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101854

Intensification of monitoring for improving detection of atrial fibrillation after a presumed “trigger- induced episode” due to potentially reversible factors: what tools and what implications for decision making?

Boriani, G., Cherubini, B., & Mei, D. A. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106660

Evolution in the approach to atrial fibrillation: from screening for asymptomatic episodes to implementing artificial intelligence for refined risk prediction

Boriani, G., & Mei, D. A. (2025) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001814

Relationship between atrial fibrillation ablation and gross domestic product across Europe

Xhakupi, H., Ameri, P., & Porto, I. (2026) · EP Europace · doi:10.1093/europace/euaf309

Early differentiation between paroxysmal and persistent atrial fibrillation based on interpretable machine learning: a multicenter retrospective study

Li, S., Zhang, Y., Wu, W., Li, G., Huang, T., Zeng, K., Tong, C., Li, H., & Huang, H. (2026) · BioData Mining · doi:10.1186/s13040-026-00525-5

Alcohol consumption and incident atrial fibrillation: rethinking dose, risk, and dogma

Zuin, M., Bertini, M., & Boriani, G. (2026) · EP Europace · doi:10.1093/europace/euag029

eHealth tools in atrial fibrillation management: An ecological cross-sectional analysis and bibliometric review of research trends and knowledge gaps

Zhou, X., Zhang, S., Hu, L. I. N., Liao, L., Xie, Z., & Li, X. (2026) · Digital Health · doi:10.1177/20552076261427101

Gut microbiota dysbiosis promotes chronic kidney disease-associated atrial fibrillation through activation of the NLRP3 inflammasome

Han, X., Yu, H., Gao, Q., Wang, X., Zhang, L., Zhao, Q., Yu, L., Zhang, Y., Sui, M., & Li, Y. (2026) · EP Europace · doi:10.1093/europace/euag037

Atrial fibrillation after cavotricuspid isthmus ablation for isolated typical atrial flutter: contemporary insights from a large global federated research network

Fauchier, L., Lemrini, Y., Lenormand, T., & Bisson, A. (2026) · EP Europace · doi:10.1093/europace/euag085

Empowering atrial fibrillation detection with TabPFN and SHAP interpretation based on ECG-derived features: a dual-center temporal validation study

Chen, M., Li, T., Wang, Z., Fan, X., Xu, H., Zhou, Y.-N., & Hu, M. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05936-0

Factors influencing kinesiophobia after radiofrequency catheter ablation in patients with atrial fibrillation: a cross-sectional study

Zheng, Y., Xu, R., Mengying, Y., Zhang, H., Zuo, T., & Yu, P. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1807261

Safety and effectiveness of the TactiFlex duo system: 6-month results of the FOCALFLEX study

Manninger, M., Scherr, D., Bulava, A., Kalman, J. M., Sanders, P., Bella, P. E. D., Martinek, M., Deisenhofer, I., Wijnmaalen, A. P., Osca, J., et al. (2026) · EP Europace · doi:10.1093/europace/euag108

Comprehensive assessment of novel cardiovascular biomarkers in AF

Ohlrogge, A. H., Engler, D., Schlieker, P., Seum, F., Rosebrock, K., Nebel, N., Csengeri, D., Fabritz, L., Ziegler, A., Blankenberg, S., et al. (2026) · EP Europace · doi:10.1093/europace/euag096

More than an OPTION: left atrial appendage closure beyond high bleeding risk in the post-ablation setting

Schiavone, M., & Biase, L. D. (2026) · EP Europace · doi:10.1093/europace/euag119

Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk – a sub-analysis of the OPTION study

Phillips, K. P., Nair, D. G., Boersma, L. V. A., Doshi, R. N., Healey, J. S., Jaber, W. A., MANSOUR, M. C., Reddy, V. Y., Tondo, C., Natale, A., et al. (2026) · EP Europace · doi:10.1093/europace/euag093

The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice

Boriani, G., Mei, D. A., Vitolo, M., & Imberti, J. F. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04006-1 · Cited by 22

Analysis of The 2024 ESC/EACTS Guidelines For The Management Of Atrial Fibrillation

Ripoll, J. G., Chang, M. G., Bittner, E. A., Ortoleva, J. P., Khromava, M., Bradley, D. T., Griffin, E. K., Soto, J. C. D., Wieruszewski, P. M., Chang, K., et al. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.11.020 · Cited by 8

AF-CARE: The current approach in atrial fibrillation management

Rizal, A. (2025) · Heart Science Journal · doi:10.21776/ub.hsj.2025.006.02.1

The 2024 European Society of Cardiology Atrial Fibrillation Guidelines: A Moving Goalpost

Dan, G., & Martínez‐Rubio, A. (2025) · European Cardiology Review · doi:10.15420/ecr.2024.55 · Cited by 2

A Holistic Approach to Improving Outcomes in Atrial Fibrillation: The AF-CARE Pathway

Griffin, M., & Mills, M. T. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0929 · Cited by 1